Estonia announces Q1, Q3 and Q4 DCP slots for drug submissions
This article was originally published in SRA
Executive Summary
Estonian medicines regulator Ravimiamet has slots available for companies wishing to make marketing authorisation submissions via the EU decentralised procedure in the first, third and fourth quarters of 20121.